Confidently choose DUROLANE for your patients.
Proven in more clinical studies than any other single-injection hyaluronic acid knee therapy, DUROLANE has been shown to be safe and effective.
During the DUROLANE pivotal trial:17
- No serious adverse events were considered related to DUROLANE treatment.17
- The most common adverse events were arthralgia (8.6%), injection site pain (2.3%), and joint swelling (1.7%).17
DUROLANE is safe for repeated courses of therapy. Repeat administration of a course of DUROLANE therapy does not increase the incidence of adverse events.10,17
Choose DUROLANE for Longer-lasting Results
- Increased residence time in the knee joint ‡27,29-32
- A half-life of 4 weeks in the knee joint, in both animals and humans.16,29
- The longest reported half-life of any hyaluronic acid product.29-32
‡The clinical relevance of this information has not been determined.